Innogen  ·  Publications  ·  Book chapters
Patents, patients and consent: Exploring the interface between regulation and innovation regimes

Laurie, G

January 2007

in ‘The Regulatory Challenge of Biotechnology: Human Genetics, Food and Patents’

Somsen, H (ed)

Edward Elgar Publishing   www.e-elgar.co.uk

ISBN 978 1 84542 489 3 (hardback), 978 1 84720 441 7 (online)

Biotechnology has prompted a revolution in science and society in the truest sense of the word. For what superficially appears to be a revolution in biotechnology, in effect touches upon the fundamentals of life and the way in which humans relate to it. This book will make a significant contribution to the debate surrounding the effective regulation of biotechnology.

The contributing authors assess how regulatory regimes can accommodate the many different and often conflicting issues to which biotechnology is giving rise to (including a very tainted public image). The book’s ultimate aim is to explore ways of designing a regulatory regime that takes heed of these different demands whilst, at the same time, answering to the imperatives of effectiveness and efficiency.

The book synthesizes three fields of legal analysis; the first focuses on the risk-dominated regulation of GM food and bio-agriculture; the second involves human genetics as a field dominated by considerations of ethics. Finally, patent law has been chosen as an area captured by notions of property.

With its holistic approach, The Regulatory Challenge of Biotechnology will be of great interest to academics, policymakers and regulators as well as biotechnology and law students.